Literature DB >> 12606541

Collagen gene expression and the altered accumulation of scleral collagen during the development of high myopia.

Alex Gentle1, Yanyan Liu, Jennifer E Martin, Giada L Conti, Neville A McBrien.   

Abstract

The development of high myopia is associated with reduced scleral collagen accumulation, scleral thinning, and loss of scleral tissue, in both humans and animal models. Reduced collagen fibril diameter is also observed in the sclera of eyes with high myopia. The present study investigated aspects of scleral collagen synthesis and degradation, in a mammalian model of high myopia, to elucidate the factors underlying scleral changes. General synthesis and degradation of scleral collagen was investigated in monocularly deprived tree shrews, through the in vivo administration of [(3)H]proline and subsequent assay of scleral tissue for [(3)H]collagen. In addition, PCR enriched cDNA, produced from tree shrew scleral mRNA, was used to synthesize probes for hybridization to custom gene arrays consisting of partial sequences for 11 collagen subtypes. Finally, real-time reverse transcriptase-PCR was employed to investigate collagen type I, III, and V mRNA expression in the sclera of myopic, contralateral control, and normal tree shrew eyes. Scleral [(3)H]proline incorporation was reduced at the posterior pole of myopic eyes following 5 days of monocular deprivation (-36 +/- 4%), whereas [(3)H]proline content was similar in treated and control eyes before myopia induction (-1 +/- 8%) but was reduced in myopic eyes following 5 (-8 +/- 2%), 12 (-15 +/- 4%), and 24 (-10 +/- 4%) days of myopia induction. The majority of the collagens investigated were found to be expressed in the sclera, with 11 subtypes being identified. Collagen type I mRNA expression was reduced in the sclera of myopic eyes (-20 +/- 7%), however, collagen type III (+2 +/- 9%) and type V (-1 +/- 6%) expression was unchanged relative to control, resulting in a net increase in the ratio of expression of collagen type III/type I and collagen type V/type I (22 and 25%, respectively). These results show that reduced scleral collagen accumulation in myopic eyes is a result of both decreased collagen synthesis and accelerated collagen degradation. Furthermore, changes in collagen synthesis are driven by reduced type I collagen production. Short term increases in the ratio of newly synthesized collagen type III/type I and type V/type I are likely to be important in the increasing frequency of small diameter scleral collagen fibrils observed in high myopia and may be important in the subsequent development of posterior staphyloma in humans with pathological myopia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12606541     DOI: 10.1074/jbc.M300970200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  66 in total

1.  Change in the synthesis rates of ocular retinoic acid and scleral glycosaminoglycan during experimentally altered eye growth in marmosets.

Authors:  David Troilo; Debora L Nickla; James R Mertz; Jody A Summers Rada
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-05       Impact factor: 4.799

Review 2.  Scleral Mechanisms Underlying Ocular Growth and Myopia.

Authors:  Ravi Metlapally; Christine F Wildsoet
Journal:  Prog Mol Biol Transl Sci       Date:  2015-06-12       Impact factor: 3.622

3.  Post-translationally abnormal collagens of prolyl 3-hydroxylase-2 null mice offer a pathobiological mechanism for the high myopia linked to human LEPREL1 mutations.

Authors:  David M Hudson; Kyu Sang Joeng; Rachel Werther; Abbhirami Rajagopal; MaryAnn Weis; Brendan H Lee; David R Eyre
Journal:  J Biol Chem       Date:  2015-02-02       Impact factor: 5.157

4.  Systematic assessment of the tagging polymorphisms of the COL1A1 gene for high myopia.

Authors:  Chung-Ling Liang; Kuo-Sheng Hung; Yueh-Ying Tsai; Wansu Chang; Hsin-Shih Wang; Suh-Hang Hank Juo
Journal:  J Hum Genet       Date:  2007-02-02       Impact factor: 3.172

5.  High myopia caused by a mutation in LEPREL1, encoding prolyl 3-hydroxylase 2.

Authors:  Shikma Mordechai; Libe Gradstein; Annika Pasanen; Rivka Ofir; Khalil El Amour; Jaime Levy; Nadav Belfair; Tova Lifshitz; Sara Joshua; Ginat Narkis; Khalil Elbedour; Johanna Myllyharju; Ohad S Birk
Journal:  Am J Hum Genet       Date:  2011-09-01       Impact factor: 11.025

Review 6.  The dynamic sclera: extracellular matrix remodeling in normal ocular growth and myopia development.

Authors:  Angelica R Harper; Jody A Summers
Journal:  Exp Eye Res       Date:  2015-04       Impact factor: 3.467

7.  Expression and role of specificity protein 1 in the sclera remodeling of experimental myopia in guinea pigs.

Authors:  Bo Jiang; Zhang-You Wu; Zi-Cheng Zhu; Gen-Jie Ke; Yue-Chun Wen; Si-Qin Sun
Journal:  Int J Ophthalmol       Date:  2017-04-18       Impact factor: 1.779

8.  Genetic deletion of the adenosine A2A receptor confers postnatal development of relative myopia in mice.

Authors:  Xiangtian Zhou; Qinzhu Huang; Jianhong An; Runxia Lu; Xiaoyi Qin; Liqin Jiang; Yuan Li; Jianhua Wang; Jiangfan Chen; Jia Qu
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-19       Impact factor: 4.799

9.  Selective regulation of MMP and TIMP mRNA levels in tree shrew sclera during minus lens compensation and recovery.

Authors:  John T Siegwart; Thomas T Norton
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-10       Impact factor: 4.799

10.  Gene expression signatures in tree shrew sclera in response to three myopiagenic conditions.

Authors:  Lin Guo; Michael R Frost; Li He; John T Siegwart; Thomas T Norton
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-10-21       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.